The success of copyright’s blockbuster initially sparked a boom for major pharmaceutical companies, however recent developments present a murky scenario for shareholders. Generic versions are eating into revenue, and https://janaqziq188619.frewwebs.com/40203356/the-blue-pill-and-pharma-a-precarious-investment